BAY 81-8973 PROPHYLAXIS FREQUENCY AND PHARMACOKINETICS IN RELATION TO BLEEDING RATES IN PEDIATRIC PATIENTS: SUBANALYSIS OF LEOPOLD KIDS DATA

Afonja Olubunmi; Shah Anita; Sanabria Martin; Senatore Guido; Rauchensteiner Stephan; Church Nikki

首页> 外文期刊>Pediatric blood & cancer >BAY 81-8973 PROPHYLAXIS FREQUENCY AND PHARMACOKINETICS IN RELATION TO BLEEDING RATES IN PEDIATRIC PATIENTS: SUBANALYSIS OF LEOPOLD KIDS DATA

【24h】

BAY 81-8973 PROPHYLAXIS FREQUENCY AND PHARMACOKINETICS IN RELATION TO BLEEDING RATES IN PEDIATRIC PATIENTS: SUBANALYSIS OF LEOPOLD KIDS DATA

机译：海湾81-8973预防频率和药代动力学与儿科患者的出血率有关：Leopold Kids数据的细胞分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pediatric blood & cancer》 |2018年第1期|共1页
作者
Afonja Olubunmi; Shah Anita; Sanabria Martin; Senatore Guido; Rauchensteiner Stephan; Church Nikki;
展开▼
作者单位

Bayer Leverkusen Germany;

Bayer Leverkusen Germany;

Bayer Leverkusen Germany;

Bayer Leverkusen Germany;

Bayer Leverkusen Germany;

Bayer Leverkusen Germany;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词

相似文献

外文文献
中文文献
专利

1. BAY 81-8973 PROPHYLAXIS FREQUENCY AND PHARMACOKINETICS IN RELATION TO BLEEDING RATES IN PEDIATRIC PATIENTS: SUBANALYSIS OF LEOPOLD KIDS DATA [J] . Afonja Olubunmi, Shah Anita, Sanabria Martin, Pediatric blood & cancer . 2018,第Suppla1期

机译：海湾81-8973预防频率和药代动力学与儿科患者的出血率有关：Leopold Kids数据的细胞分析
2. Continued benefit demonstrated with BAY 81-8973 prophylaxis in previously treated children with severe haemophilia A: Interim analysis from the LEOPOLD Kids extension study [J] . Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis . 2020,第期

机译：持续的福利在先前治疗的严重血友病患者中展示了湾81-8973预防A：Leopold儿童延伸研究中的临时分析
3. BAY 81-8973 safety and efficacy for prophylaxis and treatment of bleeds in previously treated children with severe haemophilia A: results of the LEOPOLD Kids Trial [J] . Ljung R., Kenet G., Mancuso M. E., Haemophilia: the official journal of the World Federation of Hemophilia . 2016,第3期

机译：BAY 81-8973预防和治疗先前治疗的严重血友病儿童的出血的安全性和有效性A：LEOPOLD儿童试验的结果
4. Visual ODLs: Co-Designing Patient-Generated Observations of Daily Living to Support Data-Driven Conversations in Pediatric Care [C] . Matthew K. Hong, Udaya Lakshmi, Thomas A. Olson, ACM Conference on Human Factors in Computing Systems . 2018

机译：视觉ODL：共同设计患者产生的日常生活观察，以支持儿科护理中的数据驱动对话
5. Prophylaxis vs. on-demand treatment with BAY 81-8973 a full-length plasma protein-free recombinant factor VIII product: results from a randomized trial (LEOPOLD II) [O] . K Kavakli, R Yang, L Rusen, -1

机译：使用BAY 81-8973（全长无血浆蛋白重组因子VIII产品）的预防与按需治疗：一项随机试验的结果（LEOPOLD II）
6. Improved Pharmacokinetics with BAY 81-8973 Versus Antihemophilic Factor (Recombinant) Plasma/Albumin-Free Method: A Randomized Pharmacokinetic Study in Patients with Severe Hemophilia A [O] . 2016

机译：BAY 81-8973与抗血友病因子（重组）血浆/不含白蛋白的方法相比，可改善药代动力学：A型严重血友病患者的随机药代动力学研究

BAY 81-8973 PROPHYLAXIS FREQUENCY AND PHARMACOKINETICS IN RELATION TO BLEEDING RATES IN PEDIATRIC PATIENTS: SUBANALYSIS OF LEOPOLD KIDS DATA

著录项

相似文献

相关主题

期刊订阅